Barros PP, Righetti G., and Sá L. (2025). Pricing Mechanisms for Multi-Indication Drugs. Available at https://papers.ssrn.com/abstract=5374679. Submitted
Gamba S., Pertile P., and Righetti G. (2025). Pricing Without Borders: Spillovers of External Reference Pricing in Pharmaceutical Regulation. Available at https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5381635. Submitted
Righetti G. (2024). The Impact of Amnog Reform in Germany On Pharmaceutical Prices. Available at https://ssrn.com/abstract=4828807. Under review
Barros PP, Righetti G. & Sá L. (2025). Pricing Mechanisms for Multi-Indication Drugs.
"External Reference Pricing with Discounts: Does It Pay to Keep a Secret?"
"New Accountability Relationship in the Public Healthcare System: The Effect of Information Release in South Africa", with Alessandro Barbazeni and Earle J. du Plooy
"The Indirect Impact of External Reference Pricing", with Paolo Pertile and Simona Gamba
"Multi-Indication Drugs and Equity Tradeoffs", with P.P. Barros, B. Haon and L. Sá
The Clinical Trial Balloon: How Strategic Evidence-Shaping Drives Drug Prices” with P.P. Barros, A. Gentilini, M. Miraldo, C. Santos